THE COMPLEMENT SYSTEM: A Rapid, Enzyme-Driven Defence Pathway That Enhances Immunity
The complement system is a powerful molecular defence network composed of more than 30 plasma proteins that circulate in the blood in an inactive form. Once triggered, these proteins activate in a precise cascade that enhances inflammation, promotes pathogen clearance and directly destroys microbes. Complement acts as a bridge between innate and adaptive immunity, amplifying immune responses and ensuring that pathogens are efficiently identified and eliminated. Although often overlooked, complement is one of the fastest components of the immune system. Its ability to opsonise microbes, recruit immune cells and form membrane-disrupting complexes makes it essential for early defence, especially against bacterial infections.
What You Need to Know
The complement system is a component of innate immunity made up of circulating plasma proteins that interact in a tightly regulated enzymatic cascade. These proteins are normally inactive but become rapidly activated in response to infection or tissue injury. Complement activity enhances immune defence by promoting inflammation, improving pathogen clearance, and directly damaging microbial membranes. Although it operates independently of antibodies, complement also works closely with humoral and cellular immunity.
Complement activation occurs through three main pathways that differ in how they are triggered but share common downstream effects:
The classical pathway, initiated when antibodies bound to antigens interact with complement proteins
The lectin pathway, activated when lectin proteins bind to specific carbohydrate patterns on microbial surfaces
The alternative pathway, which undergoes low-level spontaneous activation and is amplified on microbial membranes
Despite their different entry points, all three pathways converge on activation of C3, a central complement protein. Cleavage of C3 produces C3a and C3b. C3a acts as an inflammatory mediator, increasing vascular permeability and recruiting immune cells, while C3b binds to pathogen surfaces and acts as an opsonin, a molecular tag that enhances phagocytosis. Continued complement activation leads to assembly of the membrane attack complex, a ring of complement proteins that inserts into microbial membranes and forms pores. This disrupts membrane integrity and causes osmotic lysis of susceptible pathogens, particularly certain bacteria.
Beyond the Basics
Complement Activation Pathways in Detail
Complement activation can begin through three distinct pathways, each suited to detecting different immune threats. The classical pathway is initiated when antibodies, most commonly IgG or IgM, bind to antigens and recruit the C1 complex. This provides a direct link between adaptive immunity and complement activation, allowing antibody recognition to rapidly trigger downstream complement effects.
The lectin pathway follows a similar enzymatic sequence but does not require antibodies. Instead, mannose-binding lectin binds to specific carbohydrate patterns on microbial surfaces, structures that are common on pathogens but rare on host cells. This allows early complement activation as part of innate immunity. The alternative pathway operates continuously at a low level through spontaneous activation of C3 in plasma. On host cells this activity is rapidly controlled, but on microbial surfaces it becomes stabilised and amplified, providing immediate defence even before antigen-specific immunity is engaged.
C3 Activation: The Amplification Hub
C3 occupies a central position in the complement system and serves as the main amplification point for all three pathways. Once activated, C3 is cleaved into C3a and C3b, each with distinct biological effects. C3b binds covalently to microbial surfaces, acting as an opsonin, a molecular label that enhances recognition and ingestion by neutrophils and macrophages through complement receptors.
C3a, together with C5a generated later in the cascade, acts as an anaphylatoxin. These small fragments increase vascular permeability and promote recruitment of immune cells to sites of infection. Because C3b binds firmly to pathogen surfaces and is difficult for microbes to remove, complement activation ensures that pathogens remain marked for elimination even as immune cells arrive.
The Membrane Attack Complex
Activation of the terminal complement components leads to formation of the membrane attack complex. This structure is assembled from C5b, C6, C7, C8, and multiple C9 molecules, which together form a pore within the target cell membrane. Insertion of this pore disrupts membrane integrity and causes osmotic lysis of susceptible organisms.
The membrane attack complex is particularly effective against Gram-negative bacteria, whose outer membranes are vulnerable to pore formation. Host cells are protected from accidental damage by regulatory proteins such as CD59, which blocks assembly of the membrane attack complex on self cell membranes. This selective targeting allows complement to destroy microbes while preserving host tissue.
Regulation and Safety Mechanisms
Complement activation is tightly controlled to prevent excessive inflammation or unintended host cell injury. Regulatory proteins including factor H, factor I, and decay-accelerating factor act at multiple points in the cascade to inactivate complement components or disrupt enzyme complexes. These controls ensure that complement activation remains localised to microbial surfaces or sites of tissue damage.
When regulation fails, complement-mediated injury can occur. Genetic deficiencies or acquired dysfunction of regulatory proteins can allow uncontrolled complement activation, leading to inflammation, endothelial injury, and tissue damage. Effective regulation is therefore as important as activation itself in maintaining immune balance.
Interactions With Adaptive Immunity
Complement supports adaptive immune responses through several mechanisms. Complement fragments deposited on antigens enhance antigen uptake and presentation by antigen-presenting cells. In B cells, binding of C3d to antigen engages complement receptors alongside the B cell receptor, lowering the threshold required for activation and promoting antibody production.
Complement improves the efficiency and magnitude of humoral immune responses. Rather than acting in isolation, the complement system integrates innate detection with adaptive immunity, strengthening immune responses at multiple levels.
Clinical Connections
Normal complement function is essential for protection against bacterial infection, particularly during early immune responses. Deficiency of key complement components reduces the ability to opsonise pathogens, generate inflammatory signals, or form the membrane attack complex. C3 deficiency is especially severe because it disrupts all three complement pathways, leading to recurrent and often serious bacterial infections. Defects in terminal complement components impair membrane attack complex formation, increasing susceptibility to Neisseria meningitidis, an organism that relies heavily on complement-mediated killing for immune control.
Several clinical patterns are closely associated with altered complement activity:
Recurrent bacterial infections in individuals with early complement component deficiencies
Increased risk of meningococcal disease with defects in C5 through C9
Reduced C3 and C4 levels during active immune complex disease
Tissue injury driven by excessive complement activation
Complement overactivation also contributes to autoimmune and inflammatory disease. In systemic lupus erythematosus, immune complexes activate the classical pathway, leading to consumption of complement proteins and ongoing inflammation. Measurement of complement components such as C3 and C4 is commonly used to assess disease activity, as falling levels often coincide with disease flares. Complement activation contributes to vascular and tissue injury in immune complex–mediated disease by recruiting leukocytes and amplifying inflammatory responses.
Targeted manipulation of complement pathways is now part of modern clinical practice. Complement inhibitors such as eculizumab block activation of C5, preventing downstream formation of the membrane attack complex. This approach is used in conditions such as paroxysmal nocturnal haemoglobinuria and atypical haemolytic uraemic syndrome, where uncontrolled complement activity drives haemolysis and endothelial injury. Complement also contributes to pathology in sepsis, organ transplantation, and other inflammatory states, making it both a diagnostic marker and a therapeutic target across a range of clinical contexts.
Concept Check
What are the three pathways of complement activation, and what triggers each one?
Why is C3 considered the central amplification point of the complement system?
How does the membrane attack complex (MAC) destroy pathogens?
How do regulatory proteins prevent complement-mediated damage to host cells?
Which clinical conditions are associated with complement deficiency or overactivation?